Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Introduction: Critically ill patients can develop hyperglycaemia even if they do not have diabetes. Intensive insulin therapy decreases morbidity and mortality rates in patients in a surgical intensive care unit (ICU) and decreases morbidity in patients in a medical ICU. The effect of this therapy on patients in a mixed medical/surgical ICU is unknown. Our goal was to assess whether the effect of intensive insulin therapy, compared with standard therapy, decreases morbidity and mortality in patients hospitalised in a mixed ICU. Methods: This is a prospective, randomised, non-blinded, single-centre clinical trial in a medical/surgical ICU. Patients were randomly assigned to receive either intensive insulin therapy to maintain glucose levels between 80 and 110 mg/dl (4.4 to 6.1 mmol/l) or standard insulin therapy to maintain glucose levels between 180 and 200 mg/dl (10 and 11.1 mmol/l). The primary end point was mortality at 28 days. Results: Over a period of 30 months, 504 patients were enrolled. The 28-day mortality rate was 32.4% (81 of 250) in the standard insulin therapy group and 36.6% (93 of 254) in the intensive insulin therapy group (Relative Risk [RR]: 1.1; 95% confidence interval [CI]: 0.85 to 1.42). The ICU mortality in the standard insulin therapy group was 31.2% (78 of 250) and 33.1% (84 of 254) in the intensive insulin therapy group (RR: 1.06; 95%CI: 0.82 to 1.36). There was no statistically significant reduction in the rate of ICU-acquired infections: 33.2% in the standard insulin therapy group compared with 27.17% in the intensive insulin therapy group (RR: 0.82; 95%CI: 0.63 to 1.07). The rate of hypoglycaemia (≤ 40 mg/dl) was 1.7% in the standard insulin therapy group and 8.5% in the intensive insulin therapy group (RR: 5.04; 95% CI: 1.20 to 21.12). Conclusions: IIT used to maintain glucose levels within normal limits did not reduce morbidity or mortality of patients admitted to a mixed medical/surgical ICU. Furthermore, this therapy increased the risk of hypoglycaemia. Trial Registration: clinicaltrials.gov Identifiers: 4374-04-13031; 094-2 in 000966421
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, intensified insulin therapy in critically-ill patients has been shown to be associated with a higher rate of severe hypoglycemic events than less aggressive glycemic control protocols.7–10”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [9]
In the citing paper
“Although a recent meta-analysis9 of 26 studies involving 13,567 patients reported no benefits in the general ICU population, it found a favorable effect of intensive glycemic control on mortality in surgical ICU patients (relative risk [RR], 0.63; confidence interval [CI], 0.44–0.91).”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“We registered every patient's age, sex, body mass index, diabetes history, type of diabetes treatment, previous infections, comorbidities, ICU admitting diagnosis, Acute Physiology and Chronic Health Evaluation (APACHE II) score [13], Sequential Organ Failure Assessment (SOFA) score [14] and Glasgow coma score.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 6×
“However, a decrease in mortality was observed in a subgroup of patients treated with intensive control for three or more days [6].”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 1×
“Furthermore, the recently finished Volume Substitution and Insulin Therapy in Severe Sepsis trial, a randomised multicentre trial designed to assess the efficacy and safety of intensive insulin therapy in patients with severe sepsis and septic shock, was stopped early for safety reasons [16].”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223 · cited 1×
“Observational studies have suggested that strict glucose control is able to reduce hospital mortality in mixed medical/surgical ICUs [7,8], but other non-experimental studies in similar settings have not confirmed that the mean glucose level is an independent risk factor for ICU mortality.”
BackgroundMcCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 1×
“Introduction Hyperglycaemia is frequently found in critically ill patients even in the absence of diabetes and it is associated with a poor prognosis [1-4].”
Background
Cited by
Items 101–200 of 318
The Place for Glycemic Control in the Surgical Patient
May, A. K., Kauffmann, R. M., & Collier, B. R. (2011) · Surgical Infections · doi:10.1089/sur.2011.019 · Cited by 37
Dysglycemia in the critically ill patient: current evidence and future perspectives
Aramendi, I., Burghi, G., & Manzanares, W. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170054 · Cited by 36
Watkinson, P., Barber, V. S., Amira, E., James, T., Taylor, R. P., & Young, J. D. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011162 · Cited by 32
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 37
Olveira, G., García‐Luna, P. P., Pereira, J. L. S., Rebollo, I., García‐Almeida, J. M., Serrano, P., Rocamora, J. A. I., Muñoz-Aguilar, A., Molina, M. A. J., & Tapia, M. J. (2012) · PubMed · doi:10.3305/nh.2012.27.6.6076 · Cited by 34
Preechasuk, L., Suwansaksri, N., Ipichart, N., Vannasaeng, S., Permpikul, C., & Sriwijitkamol, A. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.12.005 · Cited by 33
“Despite this association between sepsis severity and hyperglycemia, studies [3-9] that have aimed to normalize glucose levels have shown inconclusive findings on sepsis outcomes.”
BackgroundUyttendaele, V., Knopp, J. L., Davidson, S. M., Desaive, T., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0720-8 · Cited by 31
Surgery in the Patient with Endocrine Dysfunction
Kohl, B., & Schwartz, S. S. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.05.003 · Cited by 33
“Although there seems to be benefit with glycemic control in relation to postoperative surgical site infection,(6,35,36) there continues to be significant discussion on how this treatment modality relates to other morbidities and mortality.(37,38)”
BackgroundManagement of critically ill patients with type 2 diabetes: The need for personalised therapy
Kar, P., Jones, K. L., Horowitz, M., & Deane, A. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.693 · Cited by 37
Hsu, C.-W., Sun, S., Lin, S.-L., Huang, H.-H., & Wong, K.-F. (2012) · Critical Care · doi:10.1186/cc11299 · Cited by 31
Eslami, S., Abu–Hanna, A., de Keizer, N. F., Bosman, R. J., Spronk, P. E., de Jonge, E., & Schultz, M. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1924-3 · Cited by 26
“Although some studies showed that the implementation of GC with insulin came with the risk of hypoglycemia [5, 6, 11–13], others did not [14–18].”
How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?
Wahl, H. G. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.09.003 · Cited by 32
Lin, K., Shang, X., Guo, Y., Zhu, P.-L., Wu, Z.-Y., Jiang, H., Ruan, J., Zheng, W.-P., You, Z., & Lin, C.-J. (2018) · Angiology · doi:10.1177/0003319718758140 · Cited by 26
“Currently, guidelines have been suggested for blood glucose monitoring and control in patients with ACS with known DM or admission hyperglycemia in the acute phase, but still no consensus has been reached on treatment thresholds and glucose targets.(49) In 2012, The European Society of Cardiology published guidelines…”
BackgroundGlycemic targets in critically ill adults: A mini-review
See, K. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1719 · Cited by 28
Assessing Inpatient Glycemic Control: What are the Next Steps?
Cook, C. B., Wellik, K. E., Kongable, G. L., & Shu, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600230 · Cited by 28
Perioperative glycemic management in 2011: paradigm shifts
Maerz, L. L., & Akhtar, S. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328348beb7 · Cited by 32
Pérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2016) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.10.026 · Cited by 33
A patient-level meta-analysis of intensive glucose control in critically ill adults
Adigbli, D., Li, Y., Hammond, N., Chatoor, R., Devaux, A. G., Li, Q., Billot, L., Annane, D., Arabi, Y., Bilotta, F., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400082 · Cited by 25
The impact of glycaemic variability on the surgical patient
Dhatariya, K., Levy, N., & Hall, G. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000326 · Cited by 31
Perioperative glycaemic control for people with diabetes undergoing surgery
Bellon, F., Solà, I., Giménez‐Pérez, G., Hernández, M., Metzendorf, M., Rubinat, E., & Mauricio, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub3 · Cited by 48
Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2019) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2019.100063 · Cited by 25
Honarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006173 · Cited by 22
Fitzgerald, O., Perez‐Concha, O., Gallego, B., Saxena, M. K., Rudd, L., Metke‐Jimenez, A., & Jorm, L. R. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab060 · Cited by 27
Clinical challenges of glycemic control in the intensive care unit: A narrative review
Sreedharan, R., Martini, A., Das, G., Aftab, N., Khanna, S. K., & Ruetzler, K. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11260 · Cited by 26
What is the optimal blood glucose target in critically ill patients? A nested cohort study
Arabi, Y. M., Al-Tarifi, A., Abou‐Shala, N., Tamim, H., & Rishu, A. (2011) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.84774 · Cited by 22
Wernly, B., Lichtenauer, M., Franz, M., Kabisch, B., Muessig, J. M., Masyuk, M., Kelm, M., Hoppe, U. C., & Jung, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091586 · Cited by 22
Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes
Balintescu, A., & Mårtensson, J. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.010 · Cited by 22
Critical Care Management of Traumatic Brain Injury
Robertson, C. S., & Rangel-Castilla, L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00338-5 · Cited by 24
Drazen, J. M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1207121 · Cited by 21
Umpierrez, G. E. (2023) · New England Journal of Medicine · doi:10.1056/nejme2309442 · Cited by 21
Agus, M. S. D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V. S., Luckett, P. M., Curley, M. A. Q., Alexander, J. L., Asaro, L. A., Coughlin-Wells, K., Duva, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.023 · Cited by 20
Zhu, C., Chen, J., Pan, J., Qiu, Z., & Xu, T. (2018) · Medicine · doi:10.1097/md.0000000000011671 · Cited by 23
Wernly, B., Jirak, P., Lichtenauer, M., Franz, M., Kabisch, B., Schulze, P. C., Braun, K., Muessig, J. M., Masyuk, M., Paulweber, B., et al. (2018) · Medical Principles and Practice · doi:10.1159/000496205 · Cited by 21
Finfer, S. R. (2013) · Virulence · doi:10.4161/viru.25855 · Cited by 21
Ichaï, C., Cariou, A., Léone, M., Veber, B., & Barnoud, D. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.06.001 · Cited by 20
“Ainsi, la prise en compte des nouvelles données [2-7] a conduit à reformuler six recommandations émanant des chapitres sur « Le contrôle glycémique en réanimation » et « La réalisation pratique des apports glucidiques » comme suit.”
BackgroundSachwani, G. R., Jaehne, A. K., Jayaprakash, N., Kuzich, M., Onkoba, V., Blyden, D., & Rivers, E. P. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0122-7 · Cited by 24
Plummer, M. P., Notkina, N., Timofeev, I. S., Hutchinson, P. J., Finnis, M., & Gupta, A. K. (2018) · Critical Care · doi:10.1186/s13054-017-1933-5 · Cited by 21
Glycemic control in critically ill patients: What to do post NICE-SUGAR?
Marik, P. E. (2009) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v1.i1.3 · Cited by 19
Uijtendaal, E. V., Rijkom, J. E. F. Z., de Lange, D. W., Lalmohamed, A., van Solinge, W. W., & Egberts, T. C. G. (2015) · Critical Care · doi:10.1186/s13054-015-0959-9 · Cited by 20
Pretty, C. G. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2015 · Cited by 23
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
A Literature Review of Intensive Insulin Therapy and Mortality in Critically Ill Patients
Chen, L. (2010) · Clinical Nurse Specialist · doi:10.1097/nur.0b013e3181cf55af · Cited by 20
Maynard, G. A., Holdych, J., Kendall, H. E., Harrison, K., Montgomery, P. A., & Kulasa, K. M. (2017) · Endocrine Practice · doi:10.4158/ep161569.or · Cited by 17
Wintergerst, K. A., Foster, M. B., Sullivan, J. E., & Woods, C. R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600102 · Cited by 18
Hersh, A. M., Hirshberg, E. L., Wilson, E. L., Orme, J. F., Morris, A. H., & Lanspa, M. J. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.04.025 · Cited by 18
Critical care of burn patients. New approaches to old problems
Lavrentieva, A. (2015) · Burns · doi:10.1016/j.burns.2015.04.009 · Cited by 23
“[6] De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, et al.”
BackgroundMethodInsulin sensitivity in critically ill patients: are women more insulin resistant?
Uyttendaele, V., Chase, J. G., Knopp, J. L., Gottlieb, R., Shaw, G. M., & Desaive, T. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00807-7 · Cited by 16
Glycemic Control in the Burn Intensive Care Unit: Focus on the Role of Anemia in Glucose Measurement
Mann, E. A., Mora, A. G., Pidcoke, H. F., Wolf, S. E., & Wade, C. E. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300612 · Cited by 19
Analytic Review: Glucose Controversies in the ICU
Honiden, S., & Inzucchi, S. E. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610387892 · Cited by 17
Updates in Glycemic Management in the Hospital
Mongkolpun, W., Provenzano, B. C., & Preiser, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1274-7 · Cited by 16
Wieske, L., Harmsen, R. E., Schultz, M. J., & Horn, J. (2011) · Neurocritical Care · doi:10.1007/s12028-011-9507-x · Cited by 14
Which factors influence glycemic control in the intensive care unit?
Preiser, J., Devos, P., & Chioléro, R. L. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328335720b · Cited by 16
DeJournett, L. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400124 · Cited by 14
Hospital hypoglycemia: From observation to action
Bellam, H., & Braithwaite, S. S. (2010) · Insulin · doi:10.1016/s1557-0843(10)80007-7 · Cited by 13
Shan, L., Hao, P., & Chen, Y. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182250515 · Cited by 13
Gaies, M., Langer, M., Alexander, J. L., Steil, G. M., Ware, J., Wypij, D., Laussen, P. C., Newburger, J. W., Goldberg, C. S., Pigula, F. A., et al. (2012) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31825b549a · Cited by 13
“However, in part because of subsequent trials challenging these single-center findings [10–13] and benefits in the original Van den Berghe study being limited to certain subgroups, pediatric intensivists have not widely adopted the practice of TGC [14–16].”
ResultMazeraud, A., Polito, A., & Annane, D. (2014) · Critical Care · doi:10.1186/cc13998 · Cited by 13
JPEN Journal Club 11. Early Stopping
Koretz, R. L. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114556318 · Cited by 13
Intensive glucose control for critically ill patients: an updated meta-analysis
Fu, Y., Sun, Y., Zhang, J., & Cheng, Y. (2018) · Endocrine Connections · doi:10.1530/ec-18-0393 · Cited by 13
Poole, A. P., Finnis, M., Anstey, J. R., Bellomo, R., Bihari, S., Biradar, V., Doherty, S., Eastwood, G. M., Finfer, S. R., French, C., et al. (2020) · Critical Care and Resuscitation · doi:10.51893/2020.2.oa3 · Cited by 15
Siegelaar, S. E., Hoekstra, J. B. L., & DeVries, J. H. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.004 · Cited by 18
Glucontrol, no control, or out of control?
Schultz, M. J., Spronk, P. E., & Houckgeest, F. V. B. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1666-2 · Cited by 13
Li, X., Meng, J., Dai, X., Liu, P., Wu, Y., Wang, S., Yin, H., & Gao, S. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01471-x · Cited by 12
[Management of hyperglycemia in the hospitalized patient].
Pasquel, F. J., & Umpierrez, G. E. (2010) · PubMed · Cited by 19
Elderly patients may benefit from tight glucose control
Chin, T. L., Sauaia, A., Moore, E. E., Chandler, J. G., Harr, J. N., Johnson, J. L., & Banerjee, A. M. (2012) · Surgery · doi:10.1016/j.surg.2012.06.015 · Cited by 12
“Subsequent prospective, nonblinded RCTs in mixed medical surgical intensive care units (ICUs) found no significant difference in ICU mortality and rate of major infections, and TGC subjects had significantly more hypoglycemic episodes than CGC patients.(9,10) In addition, evaluations of neurologic and neurosurgical pa…”
Rujirojindakul, P., Liabsuetrakul, T., McNeil, E. B., Chanchayanon, T., Wasinwong, W., Oofuvong, M., Rergkliang, C., & Chittithavorn, V. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12305 · Cited by 12
“4) Smoking status, n (%) Current 21 (21) 11 (11) Former 28 (29) 32 (32) Never 48 (48) 53 (53) No data 2 (2) 4 (4) NYHA class, n (%) I 8 (8) 5 (5) II 55 (56) 65 (65) III 32 (33) 25 (25) IV 4 (4) 5 (5) ASA class, n (%) III 86 (86) 87 (87) IV 12 (12) 10 (10) V 1 (1) 3 (3) Operation, n (%) Valve replacement/repairment 39…”
van Steen, S. C. J., Rijkenberg, S., van der Voort, P. H. J., & DeVries, J. H. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0507-x · Cited by 14
Cardona, S., TSEGKA, K. G., Pasquel, F. J., Fayfman, M., Peng, L., Jacobs, S., Vellanki, P., Halkos, M. E., Guyton, R. A., Thourani, V. H., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000703 · Cited by 12
Risk and reward: extending stochastic glycaemic control intervals to reduce workload
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-00771-6 · Cited by 13
Complicaciones asociadas a la hiperglucemia en pacientes trasplantados de hígado
Builes-Montaño, C. E., Escobar, J. F. M., Londoño, C. A., Bayona, K. L. P., Restrepo, J. C., Restrepo, J. G., Toro, C. M. A., & Jaimes, F. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.08.002 · Cited by 14
“1 (1-100) Uso de NPT (porcentaje), n (%) 13 (8%)”
The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit
Tickoo, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1697603 · Cited by 12
Forbes, N., & Anders, N. R. K. (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s55649 · Cited by 11
Ulate, K. P. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e318207097e · Cited by 12
“Subsequent single-center trials failed to confirm benefits from IIT and again showed an increased incidence of hypoglycemia in the study groups (7, 8).”
BackgroundPérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2017) · Cirugía y Cirujanos (English Edition) · doi:10.1016/j.circen.2016.10.005 · Cited by 11
Mukherjee, J. J., Chatterjee, P., Saikia, M., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 18
Critical Illness Hyperglycemia in Pediatric Cardiac Surgery
Ulate, K. P., Raj, S. S., & Rotta, A. T. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600105 · Cited by 11
Review of Insulin Therapy and Pen Use in Hospitalized Patients
Davis, E. M., Foral, P. A., Dull, R. B., & Smith, A. N. (2013) · Hospital Pharmacy · doi:10.1310/hpj4805-396 · Cited by 10
Evaluation and treatment of hyperglycemia in critically ill patients.
Balloni, A., Lari, F., & Giostra, F. (2016) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 14
Nurse-Directed Blood Glucose Management in a Medical Intensive Care Unit
Compton, F., Ahlborn, R., & Weidehoff, T. (2017) · Critical Care Nurse · doi:10.4037/ccn2017922 · Cited by 10
DeJournett, J., Nekludov, M., DeJournett, L., & Wallin, M. K. E. B. (2020) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-020-00474-2 · Cited by 11
Raurell‐Torredà, M., Perez, E. C., Aragon, M. D., Ribe, R. M., Juvanteny, E. P., & Boreu, Q. F. (2011) · American Journal of Critical Care · doi:10.4037/ajcc2011117 · Cited by 9
“pared, whether in a comparison of subcutaneous insulin therapy and IIP(24,25) or between 2 IIPs with different ranges.(6,7,12,13,15,17) Other than our study, we found only 6 studies(14,19,22,24,26,27) in which mild hypoglycemic events were analyzed.”
ResultWu, Y., Pei, J., Yang, X., Cheng, Z.-D., Zhao, Y., & Xiang, B. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2012.10.003 · Cited by 10
“Interventions to control high blood glucose may be necessary to improve clinical outcomes, as shown by various trials in both children and adults [16–18].”
MethodKrinsley, J. S., & Preiser, J. (2010) · Critical Care · doi:10.1186/cc9275 · Cited by 14
“A subsequent trial from the same institution involving medical ICU patients did not yield such strikingly positive results [2], and additional randomized trials have suggested no benefi t from this intervention [ 3-7 ] or even a modest signal of harm [8].”
ResultThe potential impact of admission insulin levels on patient outcome in the intensive care unit
Rosa, G. D. L., Vasquez, E. M., Quintero, A., Donado, J. H., Marisol Bedoya, A., Restrepo, A. H., Roncancio, G. E., Cadavid, C. A., & Jaimes, F. A. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182788042 · Cited by 13
“Unauthorized reproduction of this article is prohibited. illness admitted to the ICU of Hospital Pablo Tobón Uribe in Medellin, Colombia.5 We analyzed the last 160 consecutive ICU admissions, which correspond to patients who had not received insulin or glucose before ICU admission between February and December in 200…”
MethodInfluentialSelf-citationWagstaff, A. E., & Cheung, N. W. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0444-2 · Cited by 11
Controle glicêmico em pacientes críticos na UTI
Silva, W. O. (2013) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2013.7530 · Cited by 9
Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial
Sobel, B. E. (2010) · Coronary Artery Disease · doi:10.1097/mca.0b013e3283383ebe · Cited by 13
Characterizing Glucose Changes Antecedent to Hypoglycemic Events in the Intensive Care Unit
Cook, C. B., Potter, D. J., & Kongable, G. L. (2011) · Endocrine Practice · doi:10.4158/ep11215.or · Cited by 10
Métabolisme du glucose en situation pathologique aiguë
Losser, M.-R., Damoisel, C., & Payen, D. M. (2009) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2009.02.027 · Cited by 9
Blood Sugar Targets in Surgical Intensive Care
Roth, J., Sommerfeld, O., Birkenfeld, A. L., Sponholz, C., Müller, U., & von Loeffelholz, C. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0221 · Cited by 22
Clinical benefits of tight glycaemic control: effect on the kidney
Gunst, J., & Schetz, M. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.08.003 · Cited by 9
Rickard, L., Cubas, V., Ward, S., Hanif, W., Suggett, E. L., Ismail, T., & Ghosh, S. (2016) · Practical Diabetes · doi:10.1002/pdi.2027 · Cited by 8
Complications associated with hyperglycemia in liver transplant patients
Builes-Montaño, C. E., Escobar, J. F. M., Londoño, C. A., Bayona, K. L. P., Restrepo, J. C., Restrepo, J. G., Toro, C. M. A., & Jaimes, F. A. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.08.004 · Cited by 10
Brand, D. A., Peragallo‐Dittko, V., Fazzari, M. J., Islam, S., Jacobson, A. M., & Radin, M. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0498 · Cited by 8
Hasanloei, M. A. V., Shariatpanahi, Z. V., Vahabzadeh, D., Vahabzadeh, Z., Nasiri, L., & Shargh, A. (2017) · Europe PMC (PubMed Central) · Cited by 8
Xu, B., Jiang, W., Wang, C.-Y., Weng, L., Hu, X.-Y., Peng, J., & Du, B. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.213422 · Cited by 10
“Many randomized controlled trials have demonstrated that it is difficult to achieve low BG targets for TGC without increasing the risk of severe hypoglycemia.[5,6,9,10] Based on these reports, current guidelines advocate less strict glycemic control in the setting of critical illness.”
BackgroundDuBose, J. J., Inaba, K., Branco, B. C., Barmparas, G., Lam, L., Teixeira, P. G., Belzberg, H., & Δημητριάδης, Δ. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.04.003 · Cited by 8
“[15] De La Rosa Gdel C, Donado JH, Restrepo AH, et al.”
BackgroundOptimal target range for blood glucose in hyperglycaemic patients in a neurocritical care unit
Guo, Y., Zhou, Y., Zhang, S.-Y., Wei, Q., Huang, Y., Xia, W., & Wang, S. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114530580 · Cited by 7
Nutritional Assessment and Management of the Malnourished Patient
Mason, J. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00004-4 · Cited by 8
Year in review 2008: Critical Care - metabolism
Preiser, J. (2009) · Critical Care · doi:10.1186/cc8024 · Cited by 7
Metadata
- Authors
- De La Rosa, G. D. C., Donado, J. H., Restrepo, A. H., Quintero, A. M., González, L. G., Saldarriaga, N. E., Bedoya, M., Toro, J. M., Velásquez, J. B., Valencia, J. C., Arango, C. M., Aleman, P. H., Vasquez, E. M., Chavarriaga, J. C., Yepes, A., Pulido, W., Cadavid, C. A., & GICI-HPTU, G. D. I. E. C. I.
- Affiliations
- Hospital Pablo Tobon Uribe (CO)
- Universidad Pontificia Bolivariana (CO)
- Universidad de Antioquia (CO)
- Venue
- Critical Care
- Published
- 2008-09-17
- Volume
- 12
- Issue
- 5
- Pages
- R120-R120
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2592751
- OpenAlex
- W2124463708
- Cited by
- 319
- References
- 19
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 12 · 2020: 12 · 2019: 14 · 2018: 15 · 2017: 21 · 2016: 22 · 2015: 18 · 2014: 13 · 2013: 19 · 2012: 34
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by)
- Funders
- European Society of Intensive Care Medicine
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, glycemic control, critically ill patients, ICU mortality, intensive care unit infections, hypoglycemia, hyperglycemia, insulin therapy, 28-day mortality, length of hospital stay, ICU length of stay, ICU admission rates, hospitalization rates, hospital costs
- MeSH terms
- Adult, Aged, Blood Glucose, Critical Care, Female, Hospitalization, Humans, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.